N-FORMYL-L-LEUCINE | CAS:6113-61-7

We serve N-FORMYL-L-LEUCINE CAS:6113-61-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-FORMYL-L-LEUCINE

Chemical Name:N-FORMYL-L-LEUCINE
CAS.NO:6113-61-7
Synonyms:N-FORMYL-L-LEUCINE
FOR-LEU-OH
(S)-(+)-N-formyl leucine
FORMYL-L-ALANINE
(S)-2-formamido-4-methylpentanoic acid
N-HCO-(S)-Leu
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 360.6±25.0 °C at 760 mmHg
Melting Point 142 °C
Molecular Formula C7H13NO3
Molecular Weight 159.183
Flash Point 171.9±23.2 °C
Vapour Pressure 0.0±1.7 mmHg at 25°C
Index of Refraction 1.458
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
Specific rotation:-17°~-19°
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Orlistat(CAS:96829-58-2).



Contact us for information like N-FORMYL-L-LEUCINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-HCO-(S)-Leu physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-FORMYL-L-LEUCINE Use and application,N-FORMYL-L-LEUCINE technical grade,usp/ep/jp grade.


Related News: China has asked the European Union for help in buying urgently needed medical supplies from its member countries, the China’s official Xinhua news agency said on Saturday.6,7-bis(2-methoxyethoxy)-1H-quinazolin-4-one manufacturer The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.2-Bromo-3-chloro-5-fluoropyridine supplier “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.1-(4-Chlorophenyl)-4,4-dimethyl-3-pentanone vendor “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.“Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.